AstraZeneca plc
Time frame: 1 January 2023 - 31 December 2023Article ‘Count’ and ‘Share’ for AstraZeneca plc based on listed parameters only.
The articles listed below published by authors from AstraZeneca plc, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Human Genetics |
2 | 0.93 |
Cancer Research |
1 | 0.86 |
Journal of Biological Chemistry |
3 | 0.95 |
Journal of Clinical Investigation |
3 | 1.39 |
Journal of Neuroscience |
1 | 0.18 |
Molecular Cell |
2 | 0.38 |
Nature |
7 | 1.16 |
Nature Chemical Biology |
1 | 0.09 |
Nature Communications |
29 | 9.55 |
Nature Genetics |
4 | 0.10 |
Nature Immunology |
2 | 0.26 |
Nature Neuroscience |
1 | 0.04 |
Nature Structural & Molecular Biology |
1 | 0.82 |
Proceedings of the National Academy of Sciences of the United States of America |
4 | 1.67 |
Science |
1 | 0.01 |
Science Advances |
5 | 0.45 |
Science Translational Medicine |
1 | 0.29 |
The EMBO Journal |
3 | 0.40 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.